Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Exploratory Study of Fosrolapitant and Palonosetron Hyerocthoride for the Prevention of Nausea and Vomiting Induced by Highly Emetogenic ADC Therapy in Patients With Solid Tumors

NCT07841210 is registered in ClinicalTrials.gov with Union Hospital, Tongji Medical College, Huazhong University of Science and Technology as lead sponsor.

NCT NCT07841210
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07841210 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Exploratory Study of Fosrolapitant and Palonosetron Hyerocthoride for the Prevention of Nausea and Vomiting Induced by Highly Emetogenic ADC Therapy in Patients With Solid Tumors
Lead sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase
Phase 2
Overall status
Active, not recruiting
Start date
September 14, 2026
Completion date
January 31, 2028
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumor cancer